Ameritas Investment Partners, Inc. - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 323 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,618,037
+2.2%
42,357
-3.5%
0.06%
+8.3%
Q2 2023$1,583,906
-8.1%
43,912
-2.7%
0.06%
-11.8%
Q1 2023$1,723,095
-26.2%
45,119
-0.7%
0.07%
-27.7%
Q4 2022$2,336,062
+28.3%
45,431
-1.4%
0.09%
+14.6%
Q3 2022$1,821,000
-11.9%
46,073
-1.9%
0.08%
-7.9%
Q2 2022$2,066,000
+7.0%
46,967
-3.0%
0.09%
+29.0%
Q1 2022$1,930,000
-0.8%
48,4040.0%0.07%
+4.5%
Q4 2021$1,946,000
-1.8%
48,404
-0.7%
0.07%
-8.3%
Q3 2021$1,982,000
-7.6%
48,722
+3.2%
0.07%
-6.5%
Q2 2021$2,145,000
+12.0%
47,226
+2.8%
0.08%
+5.5%
Q1 2021$1,915,000
-3.1%
45,936
-0.7%
0.07%
-19.8%
Q4 2020$1,976,000
+550.0%
46,259
+299.7%
0.09%
+550.0%
Q3 2020$304,000
-5.6%
11,573
-3.5%
0.01%
-6.7%
Q2 2020$322,000
+53.3%
11,998
+2.9%
0.02%
+25.0%
Q1 2020$210,000
-2.8%
11,656
-4.5%
0.01%
+20.0%
Q4 2019$216,000
+14.3%
12,2010.0%0.01%
+11.1%
Q3 2019$189,000
-10.0%
12,2010.0%0.01%
-10.0%
Q2 2019$210,000
+22.1%
12,201
+14.2%
0.01%
+25.0%
Q1 2019$172,000
+10.3%
10,6850.0%0.01%
-11.1%
Q4 2018$156,000
-19.6%
10,6850.0%0.01%0.0%
Q3 2018$194,000
+7.8%
10,6850.0%0.01%0.0%
Q2 2018$180,000
-9.5%
10,685
+5.1%
0.01%
-10.0%
Q1 2018$199,000
-3.4%
10,1680.0%0.01%
+11.1%
Q4 2017$206,000
+68.9%
10,168
+8.0%
0.01%
+50.0%
Q3 2017$122,000
+0.8%
9,4160.0%0.01%0.0%
Q2 2017$121,000
-0.8%
9,4160.0%0.01%0.0%
Q1 2017$122,0009,4160.01%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
SNYDER CAPITAL MANAGEMENT L P 4,324,232$165,185,6623.73%
Steamboat Capital Partners, LLC 196,898$7,521,5042.79%
2Xideas AG 600,799$22,950,5222.54%
BERNZOTT CAPITAL ADVISORS 171,808$6,563,0662.26%
Redwood Investments, LLC 328,459$12,547,1341.70%
Mesirow Institutional Investment Management, Inc. 380,415$14,531,8531.47%
Granite Investment Partners, LLC 856,253$32,708,8651.37%
Penn Capital Management Company, LLC 324,707$12,453,2111.28%
EFG Asset Management (North America) Corp. 137,739$5,262,3191.25%
First Light Asset Management, LLC 313,536$11,977,0751.14%
View complete list of HALOZYME THERAPEUTICS INC shareholders